text
stringlengths 0
1.95M
|
|---|
data at this time. The expected life of the option granted to non-employees equals their contractual term. In the case of an extension |
of the option life, the calculation was made on the basis of the extended life. 19 Zion Oil & Gas, Inc. Consolidated Condensed Notes to Financial Statements |
(Unaudited) Note 3 - Stockholders’ Equity (cont’d) D. Compensation Cost for |
Warrant and Option Issuances The following table sets forth information about |
the compensation cost of warrant and option issuances recognized for employees and directo For the three months ended June 30, 2022 2021 US$ thousands US$ thousands 417 1,669 For the six months ended June 30, 2022 2021 US$ thousands US$ thousands 631 2,490 The following table sets forth information about |
the compensation cost of warrant and option issuances recognized for non-employe For the three months ended June 30, 2022 2021 US$ thousands US$ thousands 3 — For the six months ended June 30, 2022 2021 US$ thousands US$ thousands 4 99 The following table sets forth information about |
the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil & Gas properti For the three months ended June 30, 2022 2021 US$ thousands US$ thousands 10 — For the six months ended June 30, 2022 2021 US$ thousands US$ thousands 17 — As of June 30, 2022, there was $ 843,000 of unrecognized |
compensation cost, related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected |
to be recognized during the remaining periods of 2022 and 2023. 20 Zion Oil & Gas, Inc. Consolidated Condensed Notes to Financial Statements |
(Unaudited) Note 3 - Stockholders’ Equity (cont’d) E. Dividend Reinvestment |
and Stock Purchase Plan (“DSPP”) On March 13, 2014 Zion filed a registration statement |
on Form S-3 that is part of a replacement registration statement that was filed with the SEC using a “shelf” registration |
process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form |
S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three year |
period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus |
became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus |
Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, |
under the prior Registration No. 333-193336. On March 27, 2014, we launched our Dividend Reinvestment |
and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s |
Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the |
Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange |
Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended. The ZNWAB warrants first became exercisable on |
May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00. As of May 2, 2017, any outstanding ZNWAB warrants |
expired. As of May 2, 2018, any outstanding ZNWAC warrants |
expired. On May 29, 2019, the Company extended the termination |
date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent |
equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the |
termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant |
as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On November 1, 2016, the Company launched a unit |
offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock |
and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.” The ZNWAE warrants became exercisable on May 1, |
2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination |
date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent |
equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the |
termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant |
as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s |
Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date |
of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice |
to the warrant holders. 21 Zion Oil & Gas, Inc. Consolidated Condensed Notes to Financial Statements |
(Unaudited) Note 3 - Stockholders’ Equity (cont’d) On May 22, 2017, the Company launched a new unit |
offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under |
the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. |
The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where |
each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price |
of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit |
purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price |
of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August |
14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $ 1.00 . On May 29, 2019, the Company extended the termination |
date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant |
as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the |
termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers |
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s |
Common Stock trades above $ 5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date |
of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced |
notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement |
(as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another |
unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities |
where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 |
(the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on |
the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise |
price of $1.00 per share. The warrant is referred to as “ZNWAG.” The warrants became exercisable on January 8, |
2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if |
the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to |
the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing |
60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another |
unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at |
$250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares |
of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired |
under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant |
exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 |
and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, |
extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. 22 Zion Oil & Gas, Inc. Consolidated Condensed Notes to Financial Statements |
(Unaudited) Note 3 - Stockholders’ Equity (cont’d) On May 29, 2019, the Company extended the termination date of the ZNWAH |
Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity |
per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of |
the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent |
equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On August 21, 2018, the Company initiated another |
unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit |
(priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of |
one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ |
on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The |
investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. |
Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. |
The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, |
2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, |
2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination |
date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant |
as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the |
termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers |
this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another |
unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit |
(priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants |
to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s |
Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units |
purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price |
of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, |
2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination |
date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant |
as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the |
termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.